enVVeno Medical Corp
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -2.9% | +5.2% | -3.5% | -5.1% | -5.4% | +0.0% | +6.6% | -7.7% | -2.5% | +6.0% | -76.6% | – | |
| – | +3.7% | -2.5% | -9.9% | -0.2% | +1.5% | -36.1% | +121.8% | -52.4% | -7.4% | -26.7% | -15.0% | – | |
| – | – | – | -120.0% | – | -155.8% | – | – | -152.8% | – | – | – | – | |
| – | +33.3% | +150.0% | +40.0% | -35.7% | -55.6% | +25.0% | +0.0% | +0.0% | -100.0% | – | – | – | |
| – | -598.2% | – | +80.8% | +56.6% | -277.7% | – | -45.7% | +29.4% | +14.5% | -33.8% | +32.4% | – | |
| – | – | -99.8% | -100.0% | – | -100.0% | – | – | – | +224.5% | – | – | – | |
| – | -671.6% | – | – | +23,437.9% | -204.0% | – | -175.5% | – | – | -130.8% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.